Trademark applications and grants for Brightgene Bio Medical Technology Co L T D. Brightgene Bio Medical Technology Co L T D has 2 trademark applications. The latest application filed is for "BRIGHTGENE"
Patent Application | Date |
---|---|
CD44 TARGETED MULTI-ARM CONJUGATE 20220096644 - 17/431541 Yuan; Jiandong ;   et al. | 2022-03-31 |
BENZOPYRIDONE HETEROCYCLIC COMPOUND AND USE THEREOF 20220064141 - 17/426219 Fang; Huaxiang ;   et al. | 2022-03-03 |
PREPARATION METHOD FOR ECTEINASCIDIN COMPOUND AND INTERMEDIATE THEREOF 20210355132 - 17/283012 YUAN; Jiandong ;   et al. | 2021-11-18 |
MULTI-ARM TARGETING ANTI-CANCER CONJUGATE 20210008218 - 16/498765 Yuan; Jiandong ;   et al. | 2021-01-14 |
Phosphoramidate Compound and Preparation Method and Crystal Thereof 20200190125 - 16/706315 Yuan; Jiandong ;   et al. | 2020-06-18 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
![]() "BRIGHTGENE" 79278137 |
BRIGHTGENE 2019-10-28 |
![]() "BRIGHTGENE" 85901429 |
BRIGHTGENE 2013-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.